Featured Research

from universities, journals, and other organizations

Low-Molecular-Weight Heparins Inhibit Tumor Growth, Study Shows

Date:
April 15, 2008
Source:
Roswell Park Cancer Institute
Summary:
Low-molecular-weight heparins block the formation of new blood vessels and prevent tumor growth, according to the results of a study. Angiogenesis -- the development of new blood vessels -- fuels cancer cell reproduction. The use of low-molecular-weight heparins (LMWHs) has been shown to extend survival in cancer patients by reducing the clotting action of blood. However, the mechanism is unclear.

Low-molecular-weight heparins block the formation of new blood vessels and prevent tumor growth, according to the results of a study by Michael Wong, MD, PhD, FRCPC, Department of Medicine, Roswell Park Cancer Institute (RPCI).

Angiogenesis − the development of new blood vessels − fuels cancer cell reproduction. The use of low-molecular-weight heparins (LMWHs) has been shown to extend survival in cancer patients by reducing the clotting action of blood. However, the mechanism is unclear.

This study tested the hypothesis that sequestering blood vessel growth factors, such as fibroblast growth factor (FGF), would interfere with angiogenesis and lead to tumor cell death. The hypothesis was tested in a model group of a highly vascularized tumors treated with varying amounts of heparin and LMWH and compared with a model group that was untreated.

Researchers report that LMWHs interfered with the signaling in the blood vessel growth pathway and significantly inhibited the growth of highly vascular tumors. This was in contrast to the non-treated model, which exhibited a large number of blood vessels and a well-constructed vasculature.

“This study indicated that low-molecular-weight heparins strip and sequester a blood vessel growth factor, in this case FGF, away from its receptor and reduce vascular tumor growth,” said Dr. Wong. “Heparins are already in clinical use and by elucidating the antitumor effects, we hope to have an immediate beneficial impact on cancer patients.”

The abstract “Low-molecular-weight heparins (LMWHs) inhibit tumor growth through the sequestration of angiogenic cytokines” was presented on April 13 at at the 2008 annual meeting of the American Association for Cancer Research in San Diego, CA.


Story Source:

The above story is based on materials provided by Roswell Park Cancer Institute. Note: Materials may be edited for content and length.


Cite This Page:

Roswell Park Cancer Institute. "Low-Molecular-Weight Heparins Inhibit Tumor Growth, Study Shows." ScienceDaily. ScienceDaily, 15 April 2008. <www.sciencedaily.com/releases/2008/04/080414212841.htm>.
Roswell Park Cancer Institute. (2008, April 15). Low-Molecular-Weight Heparins Inhibit Tumor Growth, Study Shows. ScienceDaily. Retrieved October 23, 2014 from www.sciencedaily.com/releases/2008/04/080414212841.htm
Roswell Park Cancer Institute. "Low-Molecular-Weight Heparins Inhibit Tumor Growth, Study Shows." ScienceDaily. www.sciencedaily.com/releases/2008/04/080414212841.htm (accessed October 23, 2014).

Share This



More Health & Medicine News

Thursday, October 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Orthodontist Mom Jennifer Salzer on the Best Time for Braces

Orthodontist Mom Jennifer Salzer on the Best Time for Braces

Working Mother (Oct. 22, 2014) Is your child ready? Video provided by Working Mother
Powered by NewsLook.com
U.S. Issues Ebola Travel Restrictions, Are Visa Bans Next?

U.S. Issues Ebola Travel Restrictions, Are Visa Bans Next?

Newsy (Oct. 22, 2014) Now that the U.S. is restricting travel from West Africa, some are dropping questions about a travel ban and instead asking about visa bans. Video provided by Newsy
Powered by NewsLook.com
US to Track Everyone Coming from Ebola Nations

US to Track Everyone Coming from Ebola Nations

AP (Oct. 22, 2014) Stepping up their vigilance against Ebola, federal authorities said Wednesday that everyone traveling into the US from Ebola-stricken nations will be monitored for symptoms for 21 days. (Oct. 22) Video provided by AP
Powered by NewsLook.com
Doctors Help Paralysed Man Walk Again, Patient in Disbelief

Doctors Help Paralysed Man Walk Again, Patient in Disbelief

AFP (Oct. 22, 2014) Polish doctors describe how they helped a paralysed man walk again, with the patient in disbelief at the return of sensation to his legs. Duration: 1:04 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins